ATE393164T1 - Cytotoxisches protein und dessen verwendung - Google Patents

Cytotoxisches protein und dessen verwendung

Info

Publication number
ATE393164T1
ATE393164T1 AT02786035T AT02786035T ATE393164T1 AT E393164 T1 ATE393164 T1 AT E393164T1 AT 02786035 T AT02786035 T AT 02786035T AT 02786035 T AT02786035 T AT 02786035T AT E393164 T1 ATE393164 T1 AT E393164T1
Authority
AT
Austria
Prior art keywords
protein
toxin
cytotoxic protein
produced
cytotoxic
Prior art date
Application number
AT02786035T
Other languages
English (en)
Inventor
Hiroyuki Ohno
Hiromitsu Saisho
Hideki Tanzawa
Original Assignee
Fourier Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fourier Inc filed Critical Fourier Inc
Application granted granted Critical
Publication of ATE393164T1 publication Critical patent/ATE393164T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/121—Helicobacter (G); Campylobacter (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02786035T 2001-12-05 2002-12-05 Cytotoxisches protein und dessen verwendung ATE393164T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001371210 2001-12-05

Publications (1)

Publication Number Publication Date
ATE393164T1 true ATE393164T1 (de) 2008-05-15

Family

ID=19180288

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02786035T ATE393164T1 (de) 2001-12-05 2002-12-05 Cytotoxisches protein und dessen verwendung

Country Status (25)

Country Link
US (3) US7385035B2 (de)
EP (1) EP1462457B1 (de)
JP (1) JP4776166B2 (de)
KR (1) KR100628917B1 (de)
CN (1) CN1599750B (de)
AT (1) ATE393164T1 (de)
AU (1) AU2002354096B2 (de)
BR (1) BR0215114A (de)
CA (1) CA2469154C (de)
CO (1) CO5590932A2 (de)
DE (1) DE60226277T2 (de)
ES (1) ES2305323T3 (de)
HR (1) HRP20040442A2 (de)
IL (1) IL162320A0 (de)
IS (1) IS7270A (de)
MA (1) MA27504A1 (de)
MX (1) MXPA04005459A (de)
NO (1) NO20042130L (de)
NZ (1) NZ533797A (de)
PL (1) PL370704A1 (de)
RS (1) RS49804A (de)
RU (1) RU2004117155A (de)
TW (1) TW200303919A (de)
WO (1) WO2003048199A1 (de)
ZA (1) ZA200404209B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004357586A (ja) * 2003-06-04 2004-12-24 Hiroyuki Ono 細胞障害タンパク質ｍ毒素の発現方法
WO2007072576A1 (ja) * 2005-12-21 2007-06-28 Fourier Inc. ヘリコバクターピロリ由来ｍ毒素大量発現株の製造方法
US8151835B2 (en) * 2006-08-23 2012-04-10 Fht, Inc. Automated drug delivery bag filling system
CN113567671A (zh) * 2020-04-29 2021-10-29 南京农业大学 猪血管紧张素转化酶2(ace2)多克隆抗体的制备

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218158A3 (de) 1985-09-30 1988-12-07 Asahi Kasei Kogyo Kabushiki Kaisha Menschlicher monoklonaler Antikörper, B-Zell-Linie für die Herstellung dieses Antikörpers und Verfahren zur Herstellung dieser B-Zell-Linie und Antikörper.
EP0232871A3 (de) 1986-02-07 1989-03-15 Yoshitomi Pharmaceutical Industries, Ltd. Menschlicher monoklonaler Antikörper, Hybridoma zu seiner Herstellung und seine Verwendung
JPH0798000B2 (ja) 1987-05-23 1995-10-25 萩原 義秀 ガン関連抗原特異的ヒト免疫グロブリン
US5366865A (en) 1989-04-06 1994-11-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Anti-platelet monoclonal antibody
US6787153B1 (en) 1991-06-28 2004-09-07 Mitsubishi Chemical Corporation Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
US5660827A (en) 1992-03-05 1997-08-26 Board Of Regents, The University Of Texas System Antibodies that bind to endoglin
US6004555A (en) 1992-03-05 1999-12-21 Board Of Regents, The University Of Texas System Methods for the specific coagulation of vasculature
US5965132A (en) 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5877289A (en) 1992-03-05 1999-03-02 The Scripps Research Institute Tissue factor compositions and ligands for the specific coagulation of vasculature
US6093399A (en) 1992-03-05 2000-07-25 Board Of Regents, The University Of Texas System Methods and compositions for the specific coagulation of vasculature
CN1220703A (zh) * 1996-03-29 1999-06-23 阿斯特拉公司 与幽门螺杆菌及其疫备组合物有关的核酸和氨基酸序列
US6417337B1 (en) 1996-10-31 2002-07-09 The Dow Chemical Company High affinity humanized anti-CEA monoclonal antibodies
US6348581B1 (en) 1996-10-31 2002-02-19 The Dow Chemical Company High affinity humanized anti-TAG-72 monoclonalantibodies
ATE238774T1 (de) * 1997-10-09 2003-05-15 Dexcel Pharma Technologies Ltd Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt
JP2000063280A (ja) * 1998-06-11 2000-02-29 Takeda Chem Ind Ltd 抗ヘリコバクタ―・ピロリ活性胃腸薬
RU2227752C2 (ru) 1998-11-12 2004-04-27 Новолитикс Инк. Способы перекрытия кровотока и композиции для их реализации
WO2001070955A2 (en) * 2000-03-21 2001-09-27 Elitra Pharmaceuticals, Inc. Identification of essential genes in prokaryotes

Also Published As

Publication number Publication date
MXPA04005459A (es) 2004-10-11
EP1462457A4 (de) 2005-12-21
RU2004117155A (ru) 2005-05-10
IL162320A0 (en) 2005-11-20
US20060210575A1 (en) 2006-09-21
AU2002354096A1 (en) 2003-06-17
CO5590932A2 (es) 2005-12-30
AU2002354096B2 (en) 2007-05-24
NO20042130L (no) 2004-09-01
WO2003048199A1 (fr) 2003-06-12
EP1462457B1 (de) 2008-04-23
US20080233556A1 (en) 2008-09-25
HRP20040442A2 (en) 2004-12-31
KR20050044708A (ko) 2005-05-12
JPWO2003048199A1 (ja) 2005-04-14
IS7270A (is) 2004-05-17
CN1599750A (zh) 2005-03-23
DE60226277T2 (de) 2009-07-16
TW200303919A (en) 2003-09-16
MA27504A1 (fr) 2005-09-01
US7385035B2 (en) 2008-06-10
EP1462457A1 (de) 2004-09-29
JP4776166B2 (ja) 2011-09-21
US20090208972A1 (en) 2009-08-20
BR0215114A (pt) 2005-02-01
DE60226277D1 (de) 2008-06-05
ES2305323T3 (es) 2008-11-01
KR100628917B1 (ko) 2006-09-27
CN1599750B (zh) 2010-05-12
CA2469154C (en) 2011-03-01
NZ533797A (en) 2008-07-31
CA2469154A1 (en) 2003-06-12
PL370704A1 (en) 2005-05-30
ZA200404209B (en) 2005-05-30
RS49804A (sr) 2006-10-27

Similar Documents

Publication Publication Date Title
WO2004099231A3 (en) Glycopegylation methods and proteins/peptides produced by the methods
WO2003031464A3 (en) Remodeling and glycoconjugation of peptides
MXPA05003730A (es) Eritropoyetina: remodelado y glicoconjugacion de eritropoyetina.
LU91680I2 (fr) "rilonacept et ses dérivés pharmaceutiquement acceptables (ARCALYSR)"
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
AU8052901A (en) Methods of synthesizing an oxidant and applications thereof
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
PL374178A1 (en) Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
DK1379550T3 (da) Et kimært protein omfattende non-toxisk pseudomonas exotoxin A og en type IV pilin sekvenser
ATE419268T1 (de) Haemasterlin analoge
NO20073914L (no) Biologisk aktive peptider
DE59902827D1 (de) Azidfreie, gaserzeugende Zusammensetzung
ATE378408T1 (de) Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
AU2003291972A8 (en) Pharmaceutical compositions comprising insulin and legends of insulin hexamer
ATE393164T1 (de) Cytotoxisches protein und dessen verwendung
IL173943A0 (en) Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris)
CO5590936A2 (es) Compuesto farmaceutico que contiene sfcyr iib o sfcyr iii
DK1127064T3 (da) Hidtil ukendte aminosyresekvenser, DNA, der koder for aminosyresekvenserme, antistoffer, der er rettet mod sådanne sekvenser, og forskellige anvendelser deraf
MXPA03008438A (es) Toxina insecticida de bacillus thuringiensis modificada sensible a pepsina.
AU2003296543A1 (en) Peptides having a high cysteine content
ATE443715T1 (de) Polypeptide aus haemophilus influenza
DE69919693D1 (de) Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis
DK1476582T3 (da) Nukleotidsekvens kodende for et TolC, som indeholder en heterolog aminosyresekvens
GT200200277A (es) Cis-imidazolinas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties